Search Results - "Valya Ramakrishnan"
-
1
RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas
Published in Genome research (01-11-2014)“…Studies of gene rearrangements and the consequent oncogenic fusion proteins have laid the foundation for targeted cancer therapy. To identify oncogenic fusions…”
Get full text
Journal Article -
2
MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development
Published in PloS one (21-10-2013)“…Glioblastoma cells secrete extra-cellular vesicles (EVs) containing microRNAs (miRNAs). Analysis of these EV miRNAs in the bio-fluids of afflicted patients…”
Get full text
Journal Article -
3
Comparative Analysis of Technologies for Quantifying Extracellular Vesicles (EVs) in Clinical Cerebrospinal Fluids (CSF)
Published in PloS one (22-02-2016)“…Extracellular vesicles (EVs) have emerged as a promising biomarker platform for glioblastoma patients. However, the optimal method for quantitative assessment…”
Get full text
Journal Article -
4
miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients
Published in Journal of neuro-oncology (01-06-2015)“…Analysis of extracellular vesicles (EVs) derived from plasma or cerebrospinal fluid (CSF) has emerged as a promising biomarker platform for therapeutic…”
Get full text
Journal Article -
5
Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression
Published in Proceedings of the National Academy of Sciences - PNAS (28-07-2015)“…The available evidence suggests that the lethality of glioblastoma is driven by small subpopulations of cells that self-renew and exhibit tumorigenicity. It…”
Get full text
Journal Article -
6
Radiation-induced extracellular vesicle (EV) release of miR-603 promotes IGF1-mediated stem cell state in glioblastomas
Published in EBioMedicine (01-05-2020)“…Recurrence after radiation therapy is nearly universal for glioblastomas, the most common form of adult brain cancer. The study aims to define clinically…”
Get full text
Journal Article -
7
Optimizing preservation of extracellular vesicular miRNAs derived from clinical cerebrospinal fluid
Published in Cancer biomarkers : section A of Disease markers (25-03-2016)“…Tumor specific genetic material can be detected in extracellular vesicles (EVs) isolated from blood, cerebrospinal fluid (CSF), and other biofluids of…”
Get more information
Journal Article -
8
Differential localization of glioblastoma subtype: implications on glioblastoma pathogenesis
Published in Oncotarget (03-05-2016)“…The subventricular zone (SVZ) has been implicated in the pathogenesis of glioblastoma. Whether molecular subtypes of glioblastoma arise from unique niches of…”
Get full text
Journal Article -
9
A cerebrospinal fluid microRNA signature as biomarker for glioblastoma
Published in Oncotarget (01-06-2017)Get full text
Journal Article -
10
DNAR-04. MICRORNA DEGRADATION ENHANCES GLIOBLASTOMA INTRA-TUMORAL HETEROGENEITY TO AUGMENT ACQUIRED TEMOZOLOMIDE RESISTANCE
Published in Neuro-oncology (Charlottesville, Va.) (10-11-2023)Get full text
Journal Article -
11
DNAR-14. MODULATING POPULATIONAL VARIANCE OF METHYL-GUANINE METHYL TRANSFERASE (MGMT) EXPRESSION THROUGH MICRORNA DEGRADATION: A NOVEL MECHANISM OF TEMOZOLOMIDE RESISTANCE
Published in Neuro-oncology (Charlottesville, Va.) (11-11-2024)“…O6 methyl-guanine methyltransferase (MGMT) restores alkylated DNA to its undamaged form in a stochiometric manner to prevent the cytotoxic effects of…”
Get full text
Journal Article -
12
A single-cell translocation and secretion assay (TransSeA)
Published in Lab on a chip (09-10-2018)“…Understanding biological heterogeneity at the single cell level is required for advancing insights into the complexity of human physiology and diseases. While…”
Get more information
Journal Article -
13
miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression
Published in Neuro-oncology (Charlottesville, Va.) (01-06-2012)“…Genome-wide microRNA (miRNA) profiling of 82 glioblastomas demonstrated that miR-181d was inversely associated with patient overall survival after correcting…”
Get full text
Journal Article -
14
RDNA-01. microRNA DEGRADATION MEDIATED GENETIC HETEROGENEITY AS A NOVEL MECHANISM FOR TEMOZOLOMIDE RESISTANCE IN GLIOBLASTOMA
Published in Neuro-oncology (Charlottesville, Va.) (05-11-2018)“…Abstract Temozolomide (TMZ), the standard-of-care chemotherapy for glioblastoma, is a DNA alkylating drug. At cytotoxic doses, TMZ Induces high levels of…”
Get full text
Journal Article -
15
-
16
Radiation-induced Extracellular Vesicle (EV) Release of miR-603 Promotes IGF1-mediated Stem Cell State in Glioblastomas
Published in Neurosurgery (01-12-2020)“…INTRODUCTION Release of exosomes and extracellular vesicles (EV) by glioblastomas plays key roles in modulating the tumor microenvironment and therapeutic…”
Get full text
Journal Article -
17
A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas
Published in Oncotarget (30-06-2014)“…MGMT expression is a critical determinant for therapeutic resistance to DNA alkylating agents. We previously demonstrated that MGMT expression is…”
Get full text
Journal Article -
18
A cerebrospinal fluid microRNA signature as biomarker for glioblastoma
Published in Oncotarget (15-09-2017)“…To develop a cerebrospinal fluid (CSF) miRNA diagnostic biomarker for glioblastoma. Glioblastoma tissue and matched CSF from the same patient (obtained prior…”
Get full text
Journal Article -
19
Regulation of γ-globin gene expression involves signaling through the p38 MAPK/CREB1 pathway
Published in Blood cells, molecules, & diseases (15-06-2011)“…In response to sodium butyrate and trichostatin A treatment in erythroid cells, p38 mitogen activated protein kinase (MAPK) mediates fetal hemoglobin (HbF)…”
Get full text
Journal Article -
20
Abstract LB-207: PI3Kγ inhibition suppresses glioblastoma tumorigenicity through disruption of an IL11-STAT3-MYC signaling axis between microglia and glioblastoma
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…While mutations in isocitrate dehydrogenase (IDH) gene are associated with favorable prognosis in glioblastoma patients, the biologic basis for favorable…”
Get full text
Journal Article